Skip to main content

Sah Dinah Ph.d.

Chief Scientific Officer

1 company

Sah Dinah Ph.d. is a Chief Scientific Officer at Voyager Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 1 sell.

Estimated insider holdings value: $523K based on current market prices.

Holdings by Company

VYGRJan 11, 2019
Current Shares163.7K
Value$523.0K
Net Activity-15,623
Bought: 0Sold: 15.6K

Transaction History

Showing 1 filings
DateTickerRoleTypeSharesPriceValueChg%SEC
Feb 27, 2018
VYGR
Voyager Therapeutics, Inc.
Chief Scientific OfficerSale+OE15,623$30.00$468,690.00-10.1%